For help on how to get the results you want, see our search tips.
1495 results
Medicine
Shortages Remove Shortages filter
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Summaries of opinion Remove Summaries of opinion filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Qtrilmet (updated)
metformin hydrochloride, Saxagliptin, dapagliflozin, Diabetes Mellitus, Type 2
Date of authorisation: 11/11/2019, Revision: 1, Authorised, Last updated: 30/03/2020 -
List item
Human medicine European public assessment report (EPAR): Tasigna (updated)
nilotinib, Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Date of authorisation: 19/11/2007, Revision: 36, Authorised, Last updated: 30/03/2020 -
List item
Human medicine European public assessment report (EPAR): Caelyx pegylated liposomal (updated)
doxorubicin hydrochloride, Sarcoma, Kaposi, Multiple Myeloma, Ovarian Neoplasms, Breast Neoplasms
Date of authorisation: 20/06/1996, Revision: 31, Authorised, Last updated: 27/03/2020 -
List item
Human medicine European public assessment report (EPAR): Kaletra (updated)
lopinavir, ritonavir, HIV Infections
Date of authorisation: 19/03/2001, Revision: 53, Authorised, Last updated: 27/03/2020 -
List item
Human medicine European public assessment report (EPAR): Briviact (in Italy: Nubriveo) (updated)
Brivaracetam, Epilepsy
Date of authorisation: 13/01/2016,
, Revision: 8, Authorised, Last updated: 27/03/2020
-
List item
Human medicine European public assessment report (EPAR): Veyvondi (updated)
vonicog alfa, von Willebrand Diseases
Date of authorisation: 31/08/2018,, Revision: 1, Authorised, Last updated: 27/03/2020
-
List item
Human medicine European public assessment report (EPAR): Prevenar 13 (updated)
pneumococcal polysaccharide serotype 1 / pneumococcal polysaccharide serotype 14 / pneumococcal polysaccharide serotype 18C / pneumococcal polysaccharide serotype 19A, pneumococcal polysaccharide serotype 19F / pneumococcal polysaccharide serotype 23F / pneumococcal polysaccharide serotype 3 / pneumococcal polysaccharide serotype 4, pneumococcal polysaccharide serotype 5, pneumococcal polysaccharide serotype 6A, pneumococcal polysaccharide serotype 6B / pneumococcal polysaccharide serotype 7F / pneumococcal polysaccharide serotype 9V protein, Pneumococcal Infections, Immunization
Date of authorisation: 09/12/2009, Revision: 37, Authorised, Last updated: 26/03/2020 -
List item
Human medicine European public assessment report (EPAR): Lysodren (updated)
Mitotane, Adrenal Cortex Neoplasms
Date of authorisation: 28/04/2004, Revision: 15, Authorised, Last updated: 26/03/2020 -
List item
Human medicine European public assessment report (EPAR): Gazyvaro (updated)
Obinutuzumab, Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 22/07/2014,, 
, Revision: 9, Authorised, Last updated: 26/03/2020
-
List item
Human medicine European public assessment report (EPAR): Advate (updated)
octocog alfa, Hemophilia A
Date of authorisation: 02/03/2004, Revision: 25, Authorised, Last updated: 26/03/2020 -
List item
Human medicine European public assessment report (EPAR): Dovato (updated)
dolutegravir sodium, lamivudine, HIV Infections
Date of authorisation: 01/07/2019,, Revision: 1, Authorised, Last updated: 26/03/2020
-
List item
Human medicine European public assessment report (EPAR): Sifrol (updated)
pramipexole dihydrochloride monohydrate, Restless Legs Syndrome, Parkinson Disease
Date of authorisation: 13/10/1997, Revision: 33, Authorised, Last updated: 26/03/2020 -
List item
Human medicine European public assessment report (EPAR): Pazenir (updated)
paclitaxel, Breast Neoplasms
Date of authorisation: 06/05/2019,
, Revision: 4, Authorised, Last updated: 25/03/2020
-
List item
Human medicine European public assessment report (EPAR): Lojuxta (updated)
Lomitapide, Hypercholesterolemia
Date of authorisation: 31/07/2013,, 
, Revision: 12, Authorised, Last updated: 25/03/2020
-
List item
Human medicine European public assessment report (EPAR): MabThera (updated)
rituximab, Lymphoma, Non-Hodgkin, Arthritis, Rheumatoid, Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 02/06/1998, Revision: 50, Authorised, Last updated: 25/03/2020 -
List item
Human medicine European public assessment report (EPAR): Prevymis (updated)
Letermovir, Cytomegalovirus Infections
Date of authorisation: 08/01/2018,, , Revision: 6, Authorised, Last updated: 25/03/2020
-
List item
Human medicine European public assessment report (EPAR): Qtern (updated)
Saxagliptin, dapagliflozin propanediol monohydrate, Diabetes Mellitus, Type 2
Date of authorisation: 15/07/2016, Revision: 5, Authorised, Last updated: 25/03/2020 -
List item
Human medicine European public assessment report (EPAR): Takhzyro (updated)
lanadelumab, Angioedemas, Hereditary
Date of authorisation: 22/11/2018,, 
, , Revision: 2, Authorised, Last updated: 25/03/2020
-
List item
Human medicine European public assessment report (EPAR): Mysimba (updated)
bupropion hydrochloride, naltrexone hydrochloride, Obesity, Overweight
Date of authorisation: 26/03/2015,, Revision: 15, Authorised, Last updated: 25/03/2020
-
List item
Human medicine European public assessment report (EPAR): Karvea (updated)
irbesartan, Hypertension
Date of authorisation: 26/08/1997, Revision: 38, Authorised, Last updated: 25/03/2020 -
List item
Human medicine European public assessment report (EPAR): Mirapexin (updated)
pramipexole dihydrochloride monohydrate, Restless Legs Syndrome, Parkinson Disease
Date of authorisation: 23/02/1998, Revision: 36, Authorised, Last updated: 25/03/2020 -
List item
Human medicine European public assessment report (EPAR): Ameluz (updated)
5-aminolevulinic acid hydrochloride, Keratosis, Actinic, Carcinoma, Basal Cell
Date of authorisation: 13/12/2011, Revision: 15, Authorised, Last updated: 25/03/2020 -
List item
Human medicine European public assessment report (EPAR): Kromeya (updated)
adalimumab, Arthritis, Rheumatoid, Arthritis, Juvenile Rheumatoid, Psoriasis, Arthritis, Psoriatic, Spondylitis, Ankylosing, Uveitis, Colitis, Ulcerative, Crohn Disease
Date of authorisation: 02/04/2019,, 
, Revision: 4, Withdrawn, Last updated: 25/03/2020
-
List item
Human medicine European public assessment report (EPAR): Zalasta (updated)
olanzapine, Schizophrenia, Bipolar Disorder
Date of authorisation: 27/09/2007,, Revision: 17, Authorised, Last updated: 25/03/2020
-
List item
Human medicine European public assessment report (EPAR): Vaxelis (updated)
Diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens: pertussis toxoid, filamentous haemagglutinin, pertactin, fimbriae Types 2 and 3, hepatitis B surface antigen produced in yeast cells, poliovirus (inactivated): type 1 (Mahoney), type 2 (MEF-1), type 3 (Saukett) produced in Vero cells/ Haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to meningococcal protein., Meningitis, Haemophilus, Poliomyelitis, Tetanus, Diphtheria, Whooping Cough, Hepatitis B
Date of authorisation: 15/02/2016,, Revision: 7, Authorised, Last updated: 25/03/2020